This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: JNJ MDT MSFT MA V

Stocks in this article: JNJ MDT MSFT MA V

Stock Comments / EPS Changes

Atwood Oceanics (ATW) 12-month price target was lowered at Barclays to $69. Driven by lower dayrate expectations, Barclays said.

Quest Diagnostics (DGX) numbers were boosted at Credit Suisse. Twelve-month price target is now $62. Estimates were also increased given better reimbursement trends and the Solstas purchase, Credit Suisse said. Neutral rating.

International Paper (IP) 12-month price target was cut at Barclays to $54. Increased cost inputs and interrupted production, Barclays said.

JPMorgan Chase (JPM) 12-month price target was cut to $63 at UBS. EPS momentum is not robust, but company is well-capitalized and well-positioned for improving economic conditions, UBS said. Buy rating.

Wells Fargo (WFC) price target, EPS estimates were increased at UBS. First-quarter EPS beat consensus, and company is expected to remain profitable in the mortgage business, UBS said. Twelve-month price target is $50. Neutral rating.

Wells Fargo numbers were raised at Sterne Agee. Twelve-month price target is now $51. Estimates were also increased, Company continues to see healthy deposit flows and lower expenses, Sterne Agee said. Neutral rating.

Follow TheStreet on Twitter and become a fan on Facebook

This article was written by a staff member of TheStreet.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs